In Half of Hypertensive Diabetics, Co-Administration of a Calcium Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor Achieved a Target Blood Pressure of <130/80mmHg: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes (ATTEST) Study

Calcium Channel ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Hypertensive Patients

Comparison of the Effects of an Angiotensin Converting Enzyme Inhibitor and a Calcium Channel Blocker on Blood Pressure and Respiratory Function in Patients with Hypertension and Asthma

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-198710100-00030 ◽

1987 ◽

Vol 10 ◽

pp. S79-81 ◽

Cited By ~ 6

Author(s):

Henrik Riska ◽

Brita Stenius-Aarniala ◽

Anssi R. A. Sovijärvi

Keyword(s):

Blood Pressure ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Respiratory Function ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension*1

American Journal of Hypertension ◽

10.1016/j.amjhyper.2004.02.003 ◽

2004 ◽

Vol 17 (6) ◽

pp. 495-501 ◽

Cited By ~ 82

Author(s):

K JAMERSON

Keyword(s):

Blood Pressure ◽

Combination Therapy ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Pressure Control ◽

Converting Enzyme

Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a Diuretic

Archives of Internal Medicine ◽

10.1001/archinte.165.8.936 ◽

2005 ◽

Vol 165 (8) ◽

pp. 936 ◽

Cited By ~ 228

Author(s):

Mahboob Rahman

Keyword(s):

High Risk ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Hypertensive Patients ◽

Comparison of the Effects of an Angiotensin Converting Enzyme Inhibitor and a Calcium Channel Blocker on Blood Pressure and Respiratory Function in Patients with Hypertension and Asthma

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-198706110-00030 ◽

1987 ◽

Vol 10 ◽

pp. S79-81

Author(s):

Henrik Riska ◽

Brita Stenius-Aarniala ◽

Anssi R. A. Sovijärvi

Keyword(s):

Blood Pressure ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Respiratory Function ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Clinical Effects of Calcium Channel Blocker and Angiotensin Converting Enzyme Inhibitor on Endothelial Function and Arterial Stiffness in Patients with Angina Pectoris

Journal of Korean Medical Science ◽

10.3346/jkms.2009.24.2.223 ◽

2009 ◽

Vol 24 (2) ◽

pp. 223 ◽

Cited By ~ 22

Author(s):

Kye Hun Kim ◽

Myung Ho Jeong ◽

Sook Hee Cho ◽

Jae Youn Moon ◽

Young Joon Hong ◽

...

Keyword(s):

Angina Pectoris ◽

Arterial Stiffness ◽

Endothelial Function ◽

Calcium Channel ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Clinical Effects ◽

Converting Enzyme

Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin

Hypertension ◽

10.1161/hypertensionaha.116.07797 ◽

2016 ◽

Vol 68 (3) ◽

pp. 606-613 ◽

Cited By ~ 17

Author(s):

William B. White ◽

Craig A. Wilson ◽

George L. Bakris ◽

Richard M. Bergenstal ◽

Christopher P. Cannon ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Renal cortical remodelling by NO-synthesis blockers in rats is prevented by angiotensin-converting enzyme inhibitor and calcium channel blocker

Journal of Cellular and Molecular Medicine ◽

10.1111/j.1582-4934.2001.tb00161.x ◽

2001 ◽

Vol 5 (3) ◽

pp. 276-283 ◽

Cited By ~ 14

Author(s):

C. A. Mandarim-de-Lacerda ◽

Leila M. M. Pereira

Keyword(s):

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Impact of Blood Pressure Control and Angiotensin-Converting Enzyme Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: A Post Hoc Analysis of the BENEDICT Trial

Journal of the American Society of Nephrology ◽

10.1681/asn.2006060560 ◽

2006 ◽

Vol 17 (12) ◽

pp. 3472-3481 ◽

Cited By ~ 45

Author(s):

Piero Ruggenenti ◽

Annalisa Perna ◽

Maria Ganeva ◽

Bogdan Ene-Iordache ◽

Giuseppe Remuzzi

Keyword(s):

Blood Pressure ◽

Type 2 Diabetes ◽

Enzyme Inhibitor ◽

Pressure Control ◽

Converting Enzyme ◽

Post Hoc Analysis ◽

Post Hoc ◽

New Onset

Impaired Vascular Reactivity in African-American Patients with Type 2 Diabetes Mellitus and Microalbuminuria or Proteinuria Despite Angiotensin-Converting Enzyme Inhibitor Therapy

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2005-1632 ◽

2006 ◽

Vol 91 (1) ◽

pp. 31-35 ◽

Cited By ~ 30

Author(s):

A. Jawa ◽

S. Nachimuthu ◽

M. Pendergrass ◽

S. Asnani ◽

V. Fonseca

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

African American ◽

Vascular Reactivity ◽

Enzyme Inhibitor ◽

Converting Enzyme

Angiotensin converting enzyme inhibitor therapy reduces the vascular oxidative state in normotensive patients with newly diagnosed type 2 diabetes mellitus

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(03)82335-5 ◽

2003 ◽

Vol 41 (6) ◽

pp. 285

Author(s):

Bobby V. Khan ◽

Rekha G. Menon ◽

Stamtios Lerakis

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Newly Diagnosed ◽

Oxidative State